Active, Not Recruiting
Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)
NCT03944772
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Duarte, California, United States
- Research Site Los Angeles, California, United States
- Research Site Sacramento, California, United States
- Research Site Santa Monica, California, United States